Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Ming Hu

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 18, 2006
[Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine]Jun Ma, Yi-li Wang, Hong-ming Hu, et al.
Cancer Management and Research|March 29, 2018
Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinomaHeng Dong, Hang Su, Lin Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cellsHong-Ming Hu, Hauke Winter, Jun Ma, et al.
European Journal of Immunology|July 29, 2003
Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitutionJun Ma, Walter J Urba, Lüsheng Si, et al.
Cancer Research|September 2, 2008
Efficient cross-presentation depends on autophagy in tumor cellsYuhuan Li, Li-Xin Wang, Guojun Yang, et al.
International Review of Cell and Molecular Biology|February 26, 2019
Activating the Nucleic Acid-Sensing Machinery for Anticancer ImmunityTerry Medler, Jaina M Patel, Alejandro Alice, et al.
Plos One|January 18, 2013
Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent mannerWeixia Li, Meng Zhou, Hongyan Ren, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2017
Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-PresentationGuangjie Yu, Tarsem Moudgil, Zhihua Cui, et al.
Current Oncology Reports|August 11, 2005
Immunotherapy for melanoma: the good, the bad, and the futureChristian H Poehlein, Dominik Rüttinger, Jun Ma, et al.
Nanoscale Research Letters|December 21, 2018
SPIO Enhance the Cross-Presentation and Migration of DCs and Anionic SPIO Influence the Nanoadjuvant Effects Related to Interleukin-1βHui Liu, Heng Dong, Na Zhou, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 18, 2006
[Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine]Jun Ma, Yi-li Wang, Hong-ming Hu, et al.
Cancer Management and Research|March 29, 2018
Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinomaHeng Dong, Hang Su, Lin Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cellsHong-Ming Hu, Hauke Winter, Jun Ma, et al.
European Journal of Immunology|July 29, 2003
Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitutionJun Ma, Walter J Urba, Lüsheng Si, et al.
Cancer Research|September 2, 2008
Efficient cross-presentation depends on autophagy in tumor cellsYuhuan Li, Li-Xin Wang, Guojun Yang, et al.
International Review of Cell and Molecular Biology|February 26, 2019
Activating the Nucleic Acid-Sensing Machinery for Anticancer ImmunityTerry Medler, Jaina M Patel, Alejandro Alice, et al.
Plos One|January 18, 2013
Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent mannerWeixia Li, Meng Zhou, Hongyan Ren, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2017
Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-PresentationGuangjie Yu, Tarsem Moudgil, Zhihua Cui, et al.
Current Oncology Reports|August 11, 2005
Immunotherapy for melanoma: the good, the bad, and the futureChristian H Poehlein, Dominik Rüttinger, Jun Ma, et al.
Nanoscale Research Letters|December 21, 2018
SPIO Enhance the Cross-Presentation and Migration of DCs and Anionic SPIO Influence the Nanoadjuvant Effects Related to Interleukin-1βHui Liu, Heng Dong, Na Zhou, et al.
Pageof 8